Foundation Medicine

Foundation Medicine, Inc. was founded with the mission to transform cancer care by providing deep insights into the genomic mutations that drive cancer. The company specializes in developing advanced cancer diagnostic technology, offering a portfolio of genomics laboratory tests that enable the personalization of cancer treatments. Their primary market focus is on the biomedical sector within the United States, serving patients, physicians, and researchers with comprehensive genomic data to guide treatment strategies for advanced cancer.

Notable affiliated individuals include key researchers and medical professionals who contribute to the company's innovative approach. Foundation Medicine has attracted significant investment from prominent healthcare and biotech investors. The company has achieved critical milestones in cancer diagnostics, including FDA-approved tests and partnerships with leading cancer research institutions. Overall, Foundation Medicine has made a substantial impact on personalized cancer treatment, enhancing the ability of healthcare providers to tailor therapies based on individual genomic profiles.